SUTRO BIOPHARMA, INC. Company Profile
SUTRO BIOPHARMA, INC. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Country of operation (business address): Value United States.
- Business address: Value 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, California, 94080, United States.
- Mailing address: Value 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, California, 94080, United States.
- Industry (SIC): Value 2836 Biological Products, (No Diagnostic Substances).
| Measure | Value |
|---|---|
| Country of operation (business address) | United States |
| Business address | 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, California, 94080, United States |
| Mailing address | 111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, California, 94080, United States |
| Industry (SIC) | 2836 Biological Products, (No Diagnostic Substances) |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company |
| Listed stock (Section 12(b)) | Common stock, $0.001 par value · STRO · NASDAQ 10-Q filed 2026-08-12 cover |
| Shell company | No 10-Q filed 2026-08-12 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-12 cover |
| Emerging growth company | No 10-Q filed 2026-08-12 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-12 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-23 cover |
| Voluntary filer | No 10-K filed 2026-03-23 cover |
| Former names | SUTRO BIOPHARMA INC (2009-03-11 to 2018-11-08) Fundamental Applied Biology Inc (2006-11-08 to 2007-10-24) |
| First EDGAR filing | 2006-11-08 (REGDEX) |
| SEC CIK | 1382101 |
| EIN | 452441988 |
| Phone | 650-392-8412 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |